Return to play is the goal for athletes of all ages, and standard evaluations are tried and true. But one thing they don’t explore is the impact of neuromuscular activity on ability to return to sport. Beyond strength and range of motion, it is crucial to understand the health of the neuromuscular pathway in muscles that have undergone trauma and rehabilitation before sending a patient back into the ring.
mTrigger’s Neuromuscular Deficit Test (NMDT) measures the neuromusclar activity and function of the impaired limb as compared to that of the healthy limb. While the goal may not always be 100% symmetry – i.e. 0% deficit – in athletes with lateral dominance, the NMDT protocol embedded in mTrigger’s interface provides a quick, clear picture of neuromuscular performance. “Patients walk away from a session with a number they can see improving over time, and that speaks to the power of understanding your activation. This is something with real impact that patients can understand and draw motivation from,” says founder Russ Paine, who coined the protocol.
With a built in one-minute test, patients and providers have an idea of how far they’ve come and how far there is to go on the journey through rehabilitation. The value of a concise progress measurement is universal, applying to everyday orthopedic patients as well as athletes. Truly, anyone looking to get back to normal life stands to benefit from such an evaluation.
Stay tuned for detailed reports on normative measurement standards for this protocol, anticipated Summer 2019.